91 related articles for article (PubMed ID: 1492596)
1. Tumor necrosis factor in solid tumors: increased blood levels in the metastatic disease.
Ardizzoia A; Lissoni P; Brivio F; Tisi E; Perego MS; Grassi MG; Pittalis S; Crispino S; Barni S; Tancini G
J Biol Regul Homeost Agents; 1992; 6(3):103-7. PubMed ID: 1492596
[TBL] [Abstract][Full Text] [Related]
2. A study of interactions among markers of macrophage functions in metastatic solid tumors: neopterin levels in relation to those of tumor necrosis factor-alpha and of soluble interleukin-2 receptors.
Lissoni P; Brivio F; Fumagalli L; Galimberti C; Cataldo M; Marsili MT; Brivio O; Barni S; Tancini G; Angelini A
J Biol Regul Homeost Agents; 1994; 8(1):32-5. PubMed ID: 7976492
[TBL] [Abstract][Full Text] [Related]
3. Abnormally enhanced blood concentrations of vascular endothelial growth factor (VEGF) in metastatic cancer patients and their relation to circulating dendritic cells, IL-12 and endothelin-1.
Lissoni P; Malugani F; Bonfanti A; Bucovec R; Secondino S; Brivio F; Ferrari-Bravo A; Ferrante R; Vigoré L; Rovelli F; Mandalà M; Viviani S; Fumagalli L; Gardani GS
J Biol Regul Homeost Agents; 2001; 15(2):140-4. PubMed ID: 11501971
[TBL] [Abstract][Full Text] [Related]
4. Cytokine and cytokine receptor serum levels in adult bone sarcoma patients: correlations with local tumor extent and prognosis.
Rutkowski P; Kamińska J; Kowalska M; Ruka W; Steffen J
J Surg Oncol; 2003 Nov; 84(3):151-9. PubMed ID: 14598359
[TBL] [Abstract][Full Text] [Related]
5. Role of the pineal gland in the control of macrophage functions and its possible implication in cancer: a study of interactions between tumor necrosis factor-alpha and the pineal hormone melatonin.
Lissoni P; Barni S; Tancini G; Brivio F; Tisi E; Zubelewicz B; Braczkowski R
J Biol Regul Homeost Agents; 1994; 8(4):126-9. PubMed ID: 7660855
[TBL] [Abstract][Full Text] [Related]
6. Soluble TNF and IL-2 receptors in patients with breast cancer.
Tesarová P; Kvasnicka J; Umlaufová A; Homolková H; Jirsa M; Tesar V
Med Sci Monit; 2000; 6(4):661-7. PubMed ID: 11208388
[TBL] [Abstract][Full Text] [Related]
7. Effects of granulocyte-macrophage colony stimulating factor on soluble interleukin-2 receptor serum levels and their relation to neopterin and tumor necrosis factor-alpha in cancer patients.
Crispino S; Lissoni P; Ardizzoia A; Rovelli F; Perego MS; Grassi MG; Barni S; Pittalis S; Tancini G
J Biol Regul Homeost Agents; 1993; 7(3):92-4. PubMed ID: 8135145
[TBL] [Abstract][Full Text] [Related]
8. Serum interleukin-6 levels correlate to tumor progression and prognosis in metastatic breast carcinoma.
Zhang GJ; Adachi I
Anticancer Res; 1999; 19(2B):1427-32. PubMed ID: 10365118
[TBL] [Abstract][Full Text] [Related]
9. VEGF, TNF-alpha and 8-isoprostane levels in exhaled breath condensate and serum of patients with lung cancer.
Dalaveris E; Kerenidi T; Katsabeki-Katsafli A; Kiropoulos T; Tanou K; Gourgoulianis KI; Kostikas K
Lung Cancer; 2009 May; 64(2):219-25. PubMed ID: 18845357
[TBL] [Abstract][Full Text] [Related]
10. Serum concentrations of interleukin-18 in early and advanced cancer patients: enhanced secretion in metastatic disease.
Lissoni P; Brivio F; Rovelli F; Fumagalli G; Malugani F; Vaghi M; Secondino S; Bucovec R; Gardani GS
J Biol Regul Homeost Agents; 2000; 14(4):275-7. PubMed ID: 11215816
[TBL] [Abstract][Full Text] [Related]
11. Physiopathology of IL-12 in human solid neoplasms: blood levels of IL-12 in early or advanced cancer patients, and their variations with surgery and immunotherapy.
Lissoni P; Mengo S; Mandalà M; Mauri E; Brivio F; Rovelli F; Confalonieri G; Longarini R; Bonfante A; Folli D; Meregalli S; Barni S; Tancini G; Giani L
J Biol Regul Homeost Agents; 1998; 12(1-2):38-41. PubMed ID: 9677534
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of tumor necrosis factor-alpha secretion by pentoxifylline in advanced cancer patients with abnormally high blood levels of tumor necrosis factor-alpha.
Lissoni P; Ardizzoia A; Perego MS; Grassi MG; Arosio M; D'Amico P; Cazzaniga M; Crispino S; Tancini G; Barni S
J Biol Regul Homeost Agents; 1993; 7(2):73-5. PubMed ID: 8266818
[TBL] [Abstract][Full Text] [Related]
13. Are angiogenic factors, cytokines, and soluble adhesion molecules prognostic factors in patients with renal cell carcinoma?
Dosquet C; Coudert MC; Lepage E; Cabane J; Richard F
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2451-8. PubMed ID: 9815646
[TBL] [Abstract][Full Text] [Related]
14. Serum values of tumour necrosis factor-alpha and of soluble tumour necrosis factor-R55 in melanoma patients.
Ocvirk J; Stabuc B; Rudolf Z; Galvani V; Curin-Serbec V
Melanoma Res; 2000 Jun; 10(3):253-8. PubMed ID: 10890379
[TBL] [Abstract][Full Text] [Related]
15. Serum levels of tumor necrosis factor-alpha and nutritional status in pancreatic cancer patients.
Karayiannakis AJ; Syrigos KN; Polychronidis A; Pitiakoudis M; Bounovas A; Simopoulos K
Anticancer Res; 2001; 21(2B):1355-8. PubMed ID: 11396212
[TBL] [Abstract][Full Text] [Related]
16. Effects of cancer chemotherapy on the relation between serum levels of soluble interleukin-2 receptors and CD4/CD8 ratio in patients with solid neoplasms.
Lissoni P; Barni S; Tancini G; Viviani S; Rovelli F; Rescaldani R; Fiorelli G
J Biol Regul Homeost Agents; 1989; 3(3):131-3. PubMed ID: 2560317
[TBL] [Abstract][Full Text] [Related]
17. Renal cell carcinoma-associated immune impairment that may interfere with the response to cytokine therapy.
Lauerová L; Dusek L; Simícková M; Rovný F; Spurný V; Rovný A; Slampa P; Zaloudík J; Rejthar A; Wotke J; Kovarík J
Neoplasma; 1999; 46(3):141-9. PubMed ID: 10613588
[TBL] [Abstract][Full Text] [Related]
18. Correlation between tumor necrosis factor-alpha and D-dimer levels in non-small cell lung cancer patients.
Guadagni F; Ferroni P; Basili S; Facciolo F; Carlini S; Crecco M; Martini F; Spila A; D'Alessandro R; Aloe S; Cerasoli V; Del Monte G; Mariotti S; Mineo TC; Roselli M
Lung Cancer; 2004 Jun; 44(3):303-10. PubMed ID: 15140543
[TBL] [Abstract][Full Text] [Related]
19. Influence of renal involvement on peripheral blood mononuclear cell expression behaviour of tumour necrosis factor-alpha and interleukin-6 in type 2 diabetic patients.
Navarro JF; Mora C; Gómez M; Muros M; López-Aguilar C; García J
Nephrol Dial Transplant; 2008 Mar; 23(3):919-26. PubMed ID: 17911088
[TBL] [Abstract][Full Text] [Related]
20. Circadian rhythmometry of serum endogenous tumor necrosis factor-alpha in patients with colorectal cancer metastases.
Muc-Wierzgoń M; Madej K; Baranowski M; Wierzgoń J
Eur Cytokine Netw; 1998 Jun; 9(2):193-6. PubMed ID: 9681396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
